1921
Volume 19, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645
USD

Abstract

Abstract

Antiprotozoal screening tests on a large number of nitroimidazoles provided four new compounds for extensive comparative evaluations with two known, substituted 5-nitroimidazoles. Studies have shown there are only minor or no differences in the concentrations required of these compounds for inhibiting the in vitro growth of or . However, in respect to therapeutic potency, marked differences were observed for these compounds in controlling experimental trichomoniasis and amebiasis. Ronidazole and “MF” nitroimidazole were several-fold more potent than metronidazole and dimetridazole in the treatment of infections in mice. “MF” nitroimidazole was also the most potent compound for controlling experimental intestinal amebiasis in rats. Although “MCA” nitroimidazole was the least potent in the control of amebaisis, this compound was clearly the most potent compound for controlling highly lethal infections in mice. These studies show that the antiprotozoal spectrum and potency of substituted 5-nitroimidazoles may vary greatly with minor changes in the molecule. They further demonstrate that highly potent therapeutic agents can be obtained by systematically modifying the structure of these compounds to achieve specific antiprotozoal action. These highly potent 5-nitroimidazoles appear worthy of clinical evaluation as potentially useful agents for the therapy of trichomoniasis, amebiasis, and trypanosomiasis.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.1970.19.916
1970-11-01
2017-11-21
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.1970.19.916
Loading
  • Accepted : 30 Jul 1970

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error